HighLight Capital Joins $10M Round In Chinese Innovative Drug Developer Ennovabio

For Digital Subscribers Only

Chinese innovative drug developer Ennovabio has raised a US$10 million pre-A round from healthcare-focused venture capital firm HighLight Capital, a firm founded by former CDH Investments partner Wang Hui. Another Chinese investment firm Zhangkelingyi also participated.

China Money Network

UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech


Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!


Already have an account or paid subscription? Log in


RELATED NEWS



LEAVE A REPLY